Big Health’s Acquisition of Limbix

Lowenstein Sandler represented Big Health in the transaction. Big Health, the leading provider of non-drug digital treatments for mental health, announced the acquisition of Limbix, creators...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Tonix Pharmaceuticals’ $25 Million Acquisition of FDA-Approved Products from Upsher-Smith Laboratories

Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, announced its $25 million acquisition of two...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here